Arq. Bras. Cardiol. 2024; 121(10): e20240190

Cardiac Abnormalities in Hypereosinophilic Syndromes

Viviane Tiemi Hotta ORCID logo , Rafael Ruas Nastari ORCID logo , Gardênia da Silva Lobo Oishi, Alexandre Eiji Kayano ORCID logo , Juliana Alzira Gonzales Oliveira, Ruiza Gonçalves Rocha, Ana Olga Mocumbi, Fernanda Salles Seguro, José Eduardo Krieger ORCID logo , Fábio Fernandes ORCID logo , Vera Maria Cury Salemi

DOI: 10.36660/abc.20240190i

Abstract

Hypereosinophilia (HE) is defined as an eosinophil count exceeding 1500 cells/microL in peripheral blood in two tests, performed with an interval of at least one month and/or anatomopathological confirmation of HE, with eosinophils comprising more than 20% of all nucleated cells in the bone marrow. Hypereosinophilic syndrome (HES) indicates the presence of HE with organ involvement due to eosinophil action, which can be classified as primary (or neoplastic), secondary (or reactive), and idiopathic. Cardiac involvement occurs in up to 5% of cases in the acute phase and 20% of the chronic phase of the disease, ranging from oligosymptomatic cases to fulminant acute myocarditis or chronic restrictive cardiomyopathy (Loeffler endomyocarditis). However, the degree of cardiac dysfunction does not directly correlate with the degree of eosinophilia. The cardiac involvement in HES occurs in three phases: inflammatory, thrombotic, and fibrotic. It can manifest as heart failure, arrhythmias, and thromboembolic phenomena. The diagnosis of cardiopathy is based on multimodality imaging, with an emphasis on the importance of echocardiography (echo) as the primary examination. TTE with enhanced ultrasound agents can be used for better visualization, allowing greater accuracy in assessing ventricular apex, and myocardial deformation indices, such as longitudinal strain, may be reduced, especially in the ventricular apex (reverse apical sparing). Cardiac magnetic resonance imaging allows the characterization of subendocardial late gadolinium enhancement, and endomyocardial biopsy is considered the gold standard in diagnosing cardiopathy. Treatment is based on the etiology of HES.

Cardiac Abnormalities in Hypereosinophilic Syndromes

Comments

Skip to content